Irbesartan
Average across 44 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | generic | 30 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 30 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | generic | 18 | SUPPLYING |
| Macleods Pharmaceuticals Limited | generic | 15 | SUPPLYING |
| Proficient Rx LP | repackager | 13 | SUPPLYING |
| Amneal Pharmaceuticals LLC | generic | 11 | SUPPLYING |
| Solco Healthcare US, LLC | unknown | 9 | SUPPLYING |
| Unichem Pharmaceuticals (USA), Inc. | unknown | 9 | SUPPLYING |
| Jubilant Cadista Pharmaceuticals Inc. | unknown | 9 | SUPPLYING |
| A-S Medication Solutions | repackager | 7 | SUPPLYING |
| ScieGen Pharmaceuticals Inc | unknown | 6 | SUPPLYING |
| Chartwell RX, LLC | generic | 6 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 5 | SUPPLYING |
| Aurobindo Pharma Limited | generic | 5 | SUPPLYING |
| NorthStar RxLLC | relabeler | 4 | SUPPLYING |
+ 6 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
Out of Specification for Dissolution — Recalling firm: AvKARE — Nationwide in the USA
Failed Dissolution Specifications — Recalling firm: Jubilant Cadista Pharmaceuticals, Inc. — Nationwide within the United States
Failed dissolution specifications. — Recalling firm: Jubilant Cadista Pharmaceuticals, Inc. — Nationwide within the United States
CGMP Deviations: impurity N-nitrosoirbesartan detected in API — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to major distributors who may have further distributed the product nationwide.
CGMP Deviations: impurity N-nitrosoirbesartan detected in API — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to major distributors who may have further distributed the product nationwide.
CGMP Deviations: impurity N-nitrosoirbesartan detected in API — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to major distributors who may have further distributed the product nationwide.
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million. — Recalling firm: Prinston Pharmaceutical Inc — Nationwide
